⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of MPiriQ Science Technologies GmbH and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
MPiriQ Science Technologies GmbH
↗Munich, Germany
MPiriQ is an AI-powered health technology company based in Munich, Germany, that bridges daily clinical practice with medical research. The company provides software solutions that automate documentation, structure patient data at the source, and ensure GDPR-compliant pseudonymization, allowing physicians to participate in clinical research without disrupting their daily workflows.
By transforming routine clinical data into structured, research-ready information, MPiriQ aims to accelerate medical innovation and improve healthcare efficiency. The company's platform is designed to reduce administrative burdens for medical practices while enabling broader access to clinical trials and evidence generation.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:HealthTech / Clinical Research Infrastructure
SIZE & FINANCIALS
Employees:1-50
Founded:2024
Ownership:private
Status:operating
FUNDING
Stage:Seed
Investors:HV Capital
0
CORPORATE STRUCTURE
Key Partnerships:Lilly Deutschland Stiftung (Award/Recognition context)
COMPETITION
Position:Emerging
Competitors:Nuance, Ambience, Eleos Health
LEADERSHIP
Key Executives:
Markus Haug - Managing Director
Johannes von Büren - Managing Director
Scientific Founders:Florian Schroeder, Markus Haug
LINKS
Website:mpiriq.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with MPiriQ Science Technologies GmbH. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.